CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: Siomycin A
Accession: CHEBI:225824
browse the term
Synonyms: exact_synonym: N-[3-[(3-amino-3-oxoprop-1-en-2-yl)amino]-3-oxoprop-1-en-2-yl]-2-[18-(2,3-dihydroxybutan-2-yl)-11-ethylidene-59-hydroxy-8,31-bis(1-hydroxyethyl)-26,46-dimethyl-40,43-dimethylidene-6,9,16,23,28,38,41,44,47-nonaoxo-37-propan-2-yl-27-oxa-3,13,20,56-tetrathia-7,10,17,24,36,39,42,45,48,52,58,61,62,63,64-pentadecazanonacyclo[23.23.9.329,35.12,5.112,15.119,22.154,57.01,53.032,60]tetrahexaconta-2(64),4,12(63),19(62),21,29(61),30,32(60),33,51,54,57-dodecaen-51-yl]-1,3-thiazole-4-carboxamide
related_synonym: Formula=C71H81N19O18S5; InChI=1S/C71H81N19O18S5/c1-14-37-64-83-44(22-109-64)61(103)89-52(70(13,107)34(12)93)67-85-43(23-112-67)59(101)88-48-33(11)108-68(106)40-19-36(31(9)91)35-15-16-38(50(94)49(35)79-40)78-46(25(2)3)62(104)77-29(7)56(98)74-27(5)55(97)75-30(8)57(99)90-71(69-86-45(24-113-69)60(102)87-47(32(10)92)63(105)81-37)18-17-39(80-51(71)41-20-111-66(48)82-41)65-84-42(21-110-65)58(100)76-28(6)54(96)73-26(4)53(72)95/h14-16,19-21,23-25,30-34,38,44,46-48,50-52,78,91-94,107H,4-7,17-18,22H2,1-3,8-13H3,(H2,72,95)(H,73,96)(H,74,98)(H,75,97)(H,76,100)(H,77,104)(H,81,105)(H,87,102)(H,88,101)(H,89,103)(H,90,99); InChIKey=AKFVOKPQHFBYCA-UHFFFAOYSA-N; SMILES=S1C(=NC(=C1)C(=O)NC(C(=O)NC(C(=O)N)=C)=C)C2=NC3C=4N=C(C5NC(=O)C=6N=C(C(NC(=O)C7N=C(C(NC(C(NC(C=8N=C(C3(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(C)C)NC9C(C=%10N=C(C(OC5C)=O)C=C(C(O)C)C%10C=C9)O)=C)=C)C)CC2)SC8)=O)C(O)C)=O)=CC)SC7)C(O)(C(O)C)C)SC6)SC4
xref: Chemspider:17286829; HMDB:HMDB0254959
xref_mesh: MESH:C024711
G
Ccnd1
cyclin D1
multiple interactions
ISO
siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of CCND1 protein]
CTD
PMID:27517622
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Foxm1
forkhead box M1
multiple interactions
ISO
siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of FOXM1 protein]
CTD
PMID:27517622
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Hras
HRas proto-oncogene, GTPase
multiple interactions
ISO
siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of CCND1 protein]; siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of FOXM1 protein]; siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of NFE2L2 protein]; siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of PRDX1 protein]
CTD
PMID:27517622
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Hsf1
heat shock transcription factor 1
increases activity
ISO
siomycin A results in increased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of NFE2L2 protein]
CTD
PMID:27517622
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Prdx1
peroxiredoxin 1
multiple interactions
ISO
siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of PRDX1 protein]
CTD
PMID:27517622
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all